Perez David Brian 4
4 · NEOGENOMICS INC · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Perez David Brian
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-01+12,254→ 33,890 total - Award
Restricted Stock Unit
2025-06-01+23,077→ 23,077 totalExercise: $0.00From: 2026-06-01→ Common Stock (23,077 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-06-01−12,254→ 0 totalExercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - Award
Stock Option (Right to Buy)
2025-06-01+16,107→ 16,107 totalExercise: $7.28From: 2026-06-01Exp: 2035-06-01→ Common Stock (16,107 underlying)
Holdings
- 10,000(indirect: By Trust)
Common Stock
- 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 9,730
Stock Option (Right to Buy)
Exercise: $7.34From: 2023-06-10Exp: 2029-06-10→ Common Stock (9,730 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying)
Footnotes (2)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Once vested, the shares of common stock are not subject to expiration.